|
|
Volumn 150, Issue 2, 2014, Pages 210-212
|
|
A case of refractory sézary syndrome with large-cell transformation responsive to brentuximab vedotin
a
b
b
b
b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANAPLASTIC LYMPHOMA KINASE;
BRENTUXIMAB VEDOTIN;
CD2 ANTIGEN;
CD3 ANTIGEN;
CD30 ANTIGEN;
CD7 ANTIGEN;
LACTATE DEHYDROGENASE;
STEROID;
AGED;
ANTIGEN EXPRESSION;
BLOOD CELL COUNT;
CANCER STAGING;
CASE REPORT;
CD3+ T LYMPHOCYTE;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CYTOMEGALOVIRUS INFECTION;
DEMENTIA;
DERMOEPIDERMAL JUNCTION;
DISEASE DURATION;
EPIDERMIS;
FACE MALFORMATION;
FATIGUE;
FEMALE;
FLOW CYTOMETRY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
IMMUNOPHENOTYPING;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LETTER;
LYMPH NODE BIOPSY;
LYMPHOCYTIC INFILTRATION;
MULTIPLE CYCLE TREATMENT;
MYCOSIS FUNGOIDES;
NAUSEA;
NEUROPATHY;
PAUTRIER MICROABSCESS;
PHOTOTHERAPY;
PRIORITY JOURNAL;
PRURITUS;
RADIOTHERAPY;
SEZARY SYNDROME;
SKIN BIOPSY;
SKIN DISEASE;
STEROID THERAPY;
TREATMENT DURATION;
TREATMENT RESPONSE;
ULTRAVIOLET B RADIATION;
VERY ELDERLY;
WEIGHT REDUCTION;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
CELL TRANSFORMATION, NEOPLASTIC;
FEMALE;
HUMANS;
IMMUNOCONJUGATES;
LYMPHOMA, LARGE-CELL, ANAPLASTIC;
SEZARY SYNDROME;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 84894581775
PISSN: 21686068
EISSN: None
Source Type: Journal
DOI: 10.1001/jamadermatol.2013.5741 Document Type: Letter |
|
Times cited : (13)
|
|
References (4)
|
